Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system

Authors

Anna Raper
Wenting Zhou (ORCID: https://orcid.org/0000-0002-4360-1231)
Anurag Verma (ORCID: https://orcid.org/0000-0002-5063-9107)
ANJALI TIKU OWENS (ORCID: https://orcid.org/0000-0002-9669-8495)
Colin A. Ellis (ORCID: https://orcid.org/0000-0003-2152-8106)
Benita Weathers (ORCID: https://orcid.org/0000-0002-5675-8334)
Colleen Morse Kripke (ORCID: https://orcid.org/0009-0007-3117-685X)
Katherine L. Nathanson (ORCID: https://orcid.org/0000-0002-6740-0901)
Theodore G. Drivas (ORCID: https://orcid.org/0000-0002-8717-0111)
Randall A. Oyer (ORCID: https://orcid.org/0000-0001-7554-4166)
Colin Wollack
Marylyn DeRiggi Ritchie (ORCID: https://orcid.org/0000-0002-1208-1720)
Robert A. Schnoll (ORCID: https://orcid.org/0000-0002-4089-856X)
Paul E. Wileyto

Institutions

Translational Therapeutics (United States) (US)
University of Pennsylvania Health System (US)
University of Pennsylvania (US)

Publication Details

Journal: Implementation Science
Published: 2024-08-19
DOI: https://doi.org/10.1186/s13012-024-01385-5
Citations: 5
Primary Topic: Health Systems, Economic Evaluations, Quality of Life
Type: article
Field-Weighted Citation Impact: 5.65

Funders

National Human Genome Research Institute

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system

Anna Raper, Wenting Zhou, Anurag Verma, ANJALI TIKU OWENS et al.

Aug 19, 2024

5 citations

Implementation Science

Health Systems, Economic Evaluations, Quality of Life

5.65

article

Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system

Anna Raper, Wenting Zhou, Anurag Verma, ANJALI TIKU OWENS, Colin A. Ellis, Benita Weathers, Colleen Morse Kripke, Katherine L. Nathanson, Theodore G. Drivas, Randall A. Oyer, Colin Wollack, Marylyn DeRiggi Ritchie, Robert A. Schnoll, Paul E. Wileyto

August 19, 2024article en

5 citations

Abstract

No abstract available for this paper.

Implementation ScienceVol. 19(1)

Translational Therapeutics (United States) (US), University of Pennsylvania Health System (US), University of Pennsylvania (US)

National Human Genome Research Institute

Industry, innovation and infrastructure

Openalex Percentile: Top 4%

Health Systems, Economic Evaluations, Quality of Life

5.65

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system — Anna Raper, Wenting Zhou, et al. · Implementation Science (2024) | TGRS Research Map | TGRS